Horsley JR, Jovcevski B, Wegener KL, Yu J, Pukala TL, Abell AD. Rationally designed peptide-based inhibitor of Aβ42 fibril formation and toxicity: a potential therapeutic strategy for Alzheimer's disease. Biochem J. 2020 Jun 12;477(11):2039-2054. PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.